an interaction term between pravastatin treatment and genetic variation adjusted for sex and age, and country to correct for the within-study population structure.
What determines exercise performance in congenital heart disease / New frontiers in lipid lowering
high intensity exercise (95±19 vs 100±21 vs 96±20 vs 87±16 ml; P
